AnaptysBio, Inc.ANABNASDAQ
Loading
Cash & Equivalents Over TimeExpanding
Percentile Rank83
3Y CAGR+49.5%
5Y CAGR-1.0%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
+49.5%/yr
vs -11.0%/yr prior
5Y CAGR
-1.0%/yr
Recent acceleration
Acceleration
+60.5pp
Accelerating
Percentile
P83
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $238.20M | +93.5% |
| 2024 | $123.08M | +242.2% |
| 2023 | $35.97M | -49.6% |
| 2022 | $71.31M | -85.6% |
| 2021 | $495.73M | +97.9% |
| 2020 | $250.46M | +46.5% |
| 2019 | $171.02M | +50.5% |
| 2018 | $113.60M | +39.9% |
| 2017 | $81.19M | +58.5% |
| 2016 | $51.23M | - |